viewRyah Medtech Inc

RYAH Medtech data finds 78% of male medical cannabis patients use cannabis daily or near-daily, start treatment earlier in life

Compared with women, men are more likely to start using medical cannabis at a younger age and are more likely to treat ADHD/ADD

Man in a field of cannabis
“Understanding each gender’s relationship with medical cannabis is critical for refining treatments and increasing successful patient outcomes,” CEO Greg Wagner said

RYAH Medtech Inc has released an analytics report that takes a closer look at how men use medical cannabis.

The report, which featured survey feedback from 35,069 men over 22 months, found that nearly 78% of male patients use medical cannabis on a daily or near-daily basis. 

Compared with women, which the company released a report on two weeks ago, men are more likely to begin using medical cannabis earlier in life. The top conditions men use medical cannabis to treat — anxiety, stress, depression and pain — mirror those of women, with the addition for men of ADHD/ADD.

READ: RYAH Medtech data finds women make up 45% of medical cannabis users, start treatment later in life

“Understanding each gender’s relationship with medical cannabis is critical for refining treatments and increasing successful patient outcomes,” CEO Greg Wagner said in a statement. “We were surprised to see that over 77.8% of the males surveyed were using medical cannabis for treatment on a daily or nearly daily basis and many of them had previously used cannabis for medical or recreational purposes. Since this differs significantly with the average female patient’s exposure, we hope that medical providers and researchers will be inspired to further study medical cannabis treatments that are personalized to achieve effective patient outcomes,”

Strain-wise, the data showed that male patients preferred strains that are high in THC or have a balance of THC and CBD.

The statistics used in the report were compiled from RYAH’s proprietary data pool, a HIPAA-compliant database of information. 

The company’s signature RYAH vaporizer allows patients to specifically regulate the dose and temperature of their vapor and input information about their medical cannabis use. Then, using artificial intelligence, the device can help doctors give their patients more personalized treatment recommendations.

Contact Andrew Kessel at [email protected] 

Follow him on Twitter @andrew_kessel

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Ryah Medtech Inc named herein, including the promotion by the Company of Ryah Medtech Inc in any Content on the Site, the Company receives from...


RYAH Medtech stocks the shelves with its cannabis vaporizer at Maryland...

RYAH Medtech Inc Head of Marketing and Communications Sofiya Kleschuk and Director of Product Operations Jordan Medley join Maryland Sweetspot Dispensary Manager Peter Franklin to tell Proactive Investors the two have joined forces to begin offering RYAH vaporizers to medical...

on 07/11/2019

2 min read